Genitourinary Cancer Clinical Trials

Genitourinary Cancer Clinical Trials

  • 01.0486 - A Phase II Study of Cyclophosphamide, Etoposide, and Estramustine in Metastatic, Androgen-Independent Prostate Cancer (Stage III-IV)  learn more
  • 07.0297 - ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma  learn more
  • 07.0172 - A Randomized Trial of Temsirolimus and Sorafenib as Second-Line Therapy in Patients with Advanced Renal Cell Carcinoma Who Have Failed First-Line Sunitinib Therapy  learn more
  • 08.0535 - A Study of Pazopanib versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma  learn more
  • 09.0066 - Phase III Study of Docetaxel and Atrasentan versus Docetaxel and Placebo for Patients with Advanced Hormone Refractory Prostate Cancer  learn more
  • 09.0067 -  A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer  learn more
  • 09.0144 - CHAARTED: ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer  learn more